China is making a bold move in the tech world. They've just launched three massive venture capital funds. These funds are not for just any tech startups. They're specifically for \"hard technology\" areas. Think advanced manufacturing, robotics, and other high-tech fields. The funds are huge. Each
Coforge, an Indian tech company, is making a big move. They're buying Encora for $2. 35 billion. This isn't cash changing hands, though. Instead, Coforge is offering shares in exchange for Encora. Encora's owners, like Advent International and Warburg Pincus, will get about 20% of Coforge. That's a
Six women who suffered at the hands of a Denver cardiologist are taking a stand. They claim that popular dating apps like Hinge and Tinder failed to protect them. The man, Stephen Matthews, was reported multiple times but remained active on the platforms. He even received a special promotion as a "S
A legal battle is unfolding in New York City between a luxury skyscraper and its historic neighbor. The dispute centers around damage caused by construction and unfulfilled promises. Gainsborough Studios, a co-op building dating back to 1908, is suing the developer of 220 Central Park South for over
The Reiner family's story is a complex mix of fame, struggles, and tragedy. Over the years, police visited their home multiple times, hinting at underlying issues. In 2013, 2014, 2017, and twice in 2019, law enforcement responded to various calls. These ranged from welfare checks to more serious inc
The biotech and pharma world is always full of new drugs. But once a drug is out there, how do you know how much it's really worth? This is a big question for companies and investors. A new method has been created to predict future sales using past data. This can help figure out a drug's value today
Esophageal cancer, specifically squamous cell carcinoma, is tough to beat. Doctors usually treat it with a combo of chemotherapy, radiation, and surgery. But, even with this approach, the results aren't great. So, researchers are always looking for ways to improve treatment. One promising area is i
Pfizer's stock took a hit recently, and it's all tied to a serious issue with one of their drugs. A patient in a long-term study for Hympavzi, a treatment for hemophilia, passed away due to severe complications. This news came out in December 2025, and it's got people talking. The patient had hemop
Pharmaceutical giants are making headlines again, but this time, it's not about new drugs. Merck and eight other big players have joined Pfizer, Lilly, and Novo in signing Most Favored Nation (MFN) deals. These agreements aim to make medicines more affordable by tying drug prices to the lowest price
In the world of blood banks, things are changing. New tech is stepping in to make things better. AI, Big Data, and something called the SoHO framework are now part of the mix. These tools can help blood banks work smarter, not harder. First, let's talk about AI. It's not just for sci-fi movies anym
